MSTN and type 2 diabetes mellitus: If our observations on the overexpression of myostatin are confirmed in other T2D/CLI animal models implanted with stem cells, it may suggest that such implantation may counteract at least partially the beneficial effects exerted by MDSC (or stem cells in general), and may lead to the alteration of the balance between slow and fast myofiber regeneration.